2013
DOI: 10.1097/mib.0b013e31829936a4
|View full text |Cite
|
Sign up to set email alerts
|

The Increasing Weight of Crohnʼs Disease Subjects in Clinical Trials

Abstract: We demonstrate increasing body weight over time from 1991 to 2008 in CD as evidenced by baseline data from randomized clinical trials. Adiposity may play a potential role in initiating and perpetuating intestinal inflammation, a hypothesis that should be explored further.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
59
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 84 publications
(69 citation statements)
references
References 55 publications
5
59
0
1
Order By: Relevance
“…Whereas the prevalence of malnutrition and underweight has decreased over the past years [30], patients with IBD are more often overweight or obese now, probably as a result of improved therapeutic options and prolonged remission status [31,32]. Our study data confirmed this trend.…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation
“…Whereas the prevalence of malnutrition and underweight has decreased over the past years [30], patients with IBD are more often overweight or obese now, probably as a result of improved therapeutic options and prolonged remission status [31,32]. Our study data confirmed this trend.…”
Section: Discussionsupporting
confidence: 80%
“…According to the BMI-classification of the World Health Organization (WHO), a BMI less than 18.5 kg/m² was considered as underweight, between 18.5 kg/m² to 25.0 kg/m² as normal weight, between 25.0 kg/ m² to 30.0 kg/m² as overweight (pre-obese) and over 30.0 kg/m² as obese [28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45].…”
Section: Nutritional Statusmentioning
confidence: 99%
“…2, Table 3). The largest study to date in a treatment-naïve cohort of paediatric patients with CD [61], in whom analysis of mucusol and lumen-associated microbiota was performed, confirms that inflammation 17 % of patients with CD in an Irish cohort were obese compared with 12 % of controls [47] Increased weight of patients with CD enrolling in clinical trials (1991-2008) [48] 23 % of paediatric patients with IBD in the USA were found to be overweight or obese [49] Decreased rate of surgery Cumulative probability of first major surgery at 9 years decreased from 50 % (1979-1986) to 23 % (2003-2011) in patients with CD, and from 14 to 9 % in patients with UC [50] Decreased risk of surgery in patients in whom CD was diagnosed after 1996, associated with increased specialist care [51] Increasing prevalence of elderly-onset IBD Increased proportion of colonic disease and inflammatory behaviour in elderly patients with CD [52,53] Progression of disease behaviour less than in younger patients. Milder disease course [52] BMI body mass index, CD Crohn's disease, UC ulcerative colitis J Gastroenterol (2015) 50:495-507 499 is strongly associated with an overall drop in species diversity and alterations in the abundance of several taxa.…”
Section: Microbiota Studies In Patients With Ibdmentioning
confidence: 88%
“…In that study there were significantly more obese patients with CD than with UC [46]. There has been an increase in weight and disease activity in patients with CD enrolling in clinical trials in the last 20 years [48].…”
Section: The Changing Phenotype Of Ibdmentioning
confidence: 92%
“…What is known is that obesity is being observed more frequently in IBD outpatient clinics (1,6) . This emphasizes the alarm lead by this important paper by Back et al, that demonstrated important rates of overweight and obese patients in an IBD cohort, defined with strict and detailed technical measurements.…”
Section: Dear Sirmentioning
confidence: 99%